Reva Medical Inc. has secured early CE mark and clinical implant of its 2.5 millimeter Fantom Encore bioresorbable scaffold, bringing a slimmed down version of its Fantom device to the European market. The first surgical implantation of the sirolimus-releasing scaffold with a 95 micron strut profile was completed at Universitätsklinikum Schleswig-Holstein in Kiel, Germany. Fantom Encore is X-ray visible, and uses Reva's Tyrocore polymer.